New hormone treatment for polycystic ovary syndrome
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests a new medication that combines two hormone-like drugs to treat polycystic ovary syndrome (PCOS), a condition affecting ovulation and hormone balance. The trial aims to see if this dual-action drug can improve irregular periods and other PCOS symptoms better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female, between 18 and 40 years old
- You have PCOS diagnosed by at least 2 of these: very irregular periods, multiple small cysts on ovaries (seen on ultrasound), or high male hormone levels
- You are not planning to get pregnant for at least 2 months after the study ends, and you agree to use approved birth control
- You have not used hormone birth control pills, patches, or rings in the past 2 months
- You do not have type 1 or type 2 diabetes, a history of pancreas problems, or thyroid cancer in your family
- You have not had weight-loss surgery in the past year or taken GLP-1 drugs (like Ozempic, Wegovy) in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body handles sugar (glucose) in women with a specific type of PCOS. It compares responses between women with PCOS and those without to understand metabolic changes.
This study tests a smartphone app that helps women with PCOS (a hormonal condition affecting ovulation) follow a Mediterranean diet—a heart-healthy eating pattern. The goal is to see if this diet approach can improve irregular periods and other PCOS symptoms.
This trial studies whether a team of doctors from different specialties can better diagnose and treat PCOS. If you have PCOS and are looking for a more comprehensive approach, this study may be a good fit.
This trial tests if a medicine called a GLP-1 agonist (like semaglutide) can help with hormone and ovulation problems in adolescent girls with PCOS and obesity. It aims to improve irregular periods and other PCOS symptoms.
This study tests if a GLP-1 medicine (a type of diabetes drug that also helps with weight) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial may be for you.
This study tests if a GLP-1 medication (a type of diabetes drug that also helps with weight loss) can improve pregnancy outcomes in women with PCOS who are overweight. If you have PCOS, a BMI between 28 and 35, and are trying to get pregnant, this trial might be an option for you.
Hear when a new PCOS (Polycystic Ovary Syndrome) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.